Status:
UNKNOWN
Gestational Immunity for Transfer
Lead Sponsor:
National University Hospital, Singapore
Collaborating Sponsors:
National University of Singapore
Agency for Science, Technology and Research
Conditions:
Covid19
Breastfeeding
Eligibility:
All Genders
Brief Summary
This is a study prospective cohort study at an urban academic centre, with two parts: 1. Health outcomes, and maternally transferred antibodies, in babies born to mothers who had antenatal COVID-19 a...
Detailed Description
This proposal aims to provide a multi-faceted approach to study how immunity may be transferred - both transplacentally and through breastfeeding, from mother to child, in the context of COVID-19. We...
Eligibility Criteria
Inclusion
- Lives in Singapore
Exclusion
- Prematurity Congenital abnormalities Primary immunodeficiencies Autoimmune disorders
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04802278
Start Date
May 1 2020
End Date
December 1 2021
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore